Indivior stock price target raised to $34 from $27 at Craig-Hallum

Investing.com - Craig-Hallum raised its price target on Indivior (NASDAQ:INDV) to $34.00 from $27.00 on Wednesday, maintaining a Buy rating on the pharmaceutical company’s stock. The stock has shown remarkable momentum, delivering a 175% return over the past six months and currently trading near its 52-week high of $24.66.

The price target increase follows Indivior’s announcement of its "Action Agenda," a multi-year plan to restructure operations and concentrate on the U.S. market, which was detailed in its Q2 2025 results.

According to an 8-K filing released Tuesday, the company plans to simplify its structure and improve commercial execution to drive revenue growth into 2026, with particular focus on its Sublocade product and the long-acting injectable (LAI) market.

The restructuring includes a substantial headcount reduction, though complete details about the financial impact of these changes won’t be available until late October.

Craig-Hallum believes these changes will have a material impact on Indivior’s business performance, contributing to the firm’s more optimistic outlook for the stock.

In other recent news, Indivior PLC reported impressive financial results for the second quarter of 2025, with earnings per share of $0.51, significantly outperforming the forecast of $0.24. The company’s revenue also surpassed expectations, reaching $302 million, a 24.96% increase over projections. These results highlight Indivior’s strong financial performance during the period. Additionally, Indivior has announced it will incur restructuring charges estimated between $39 million and $50 million as part of a broader initiative to streamline operations. This restructuring is part of the company’s multi-year operational plan, the Indivior Action Agenda, aimed at simplifying organizational processes. Piper Sandler has reiterated its Overweight rating on Indivior, maintaining a price target of $27.00, following the company’s detailed presentation of its efficiency initiatives. Furthermore, Indivior updated its CFO’s employment agreements, with no changes to compensation, aligning with the company’s standard forms for U.S.-based executives. These developments reflect Indivior’s ongoing efforts to enhance operational efficiency and strategic focus.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.